Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02913417
Title Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors David Minor, MD
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.